About this trial
The goal of the study is to
1. To measure wound size of chronic ulcers after using FREMS therapy and phenytoin application in the interventional group monthly till the end of the third month compared to baseline. 2. To measure wound size of chronic ulcers after using standard of care in control group monthly till the end of the third month compared to baseline. 3. To compare the results of the 2 groups and determine the significance of the treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
chronic ulcers more than 3 months.
Disqualifiers
incapable of being in the clinic of diabetic ulcer during treatment period 3 days/ week for 3 months.
severe ischemia that is indicated for a surgery.
infection or osteomyelitis.
Trial design
Parallel
Treatments tested in this trial
FREMS
Devicefrequency rhythmic electrical stimulation which is an electrical device specialized in diabetes complications like ulcers and neuropathies, with proven efficacy in neuropathies, and promising results in ulcers.
Treatment groups
Trial outcomes
Primary outcomes
healing rate
wound size
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Beni-Suef University
Lead sponsor
General Organization for Teaching Hospitals and Institutes
Collaborator
This trial is not recruiting at the moment. You can still explore other options: